InvestorsObserver
×
News Home

Is Catabasis Pharmaceuticals Inc (CATB) Stock About to Get Hot Tuesday?

Tuesday, February 02, 2021 02:13 PM | InvestorsObserver Analysts

Mentioned in this article

Is Catabasis Pharmaceuticals Inc (CATB) Stock About to Get Hot Tuesday?

The market has been down on Catabasis Pharmaceuticals Inc (CATB) stock recently. CATB gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish
Catabasis Pharmaceuticals Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CATB!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.

InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.

For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With CATB Stock Today?

Catabasis Pharmaceuticals Inc (CATB) stock is lower by -7.65% while the S&P 500 is higher by 1.71% as of 2:11 PM on Tuesday, Feb 2. CATB has fallen -$0.28 from the previous closing price of $3.64 on volume of 3,579,223 shares. Over the past year the S&P 500 has gained 18.15% while CATB has fallen -39.24%. CATB lost -$2.14 per share in the over the last 12 months.

To screen for more stocks like Catabasis Pharmaceuticals Inc click here.

More About Catabasis Pharmaceuticals Inc

Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted, a linker-drug discovery platform. The company's primary focus is on treatments for rare diseases. Its product pipeline includes CAT-1004, an oral small molecule for the treatment of Duchenne muscular dystrophy, CAT-2054 for the treatment of hypercholesterolemia and CAT-4001 which is used for the treatment of rare neurodegenerative diseases, such as Friedreich's ataxia and amyotrophic lateral sclerosis.

Click Here to get the full Stock Score Report on Catabasis Pharmaceuticals Inc (CATB) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App